PMID: 23136402

Bochem AE, van Wijk DF, Holleboom AG, Duivenvoorden R, Motazacker MM, Dallinga-Thie GM, de Groot E, Kastelein JJ, Nederveen AJ, Hovingh GK, Stroes ES
ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden.
Eur Heart J. 2013 Jan;34(4):286-91. doi: 10.1093/eurheartj/ehs376. Epub 2012 Nov 7., [PubMed]
Sentences
No. Mutations Sentence Comment
69 ABCA1 p.Asn1800His
X
ABCA1 p.Asn1800His 23136402:69:157
status: NEW
view ABCA1 p.Asn1800His details
ABCA1 p.Thr929Ile
X
ABCA1 p.Thr929Ile 23136402:69:105
status: NEW
view ABCA1 p.Thr929Ile details
ABCA1 p.Arg587Trp
X
ABCA1 p.Arg587Trp 23136402:69:92
status: NEW
view ABCA1 p.Arg587Trp details
ABCA1 p.Ser930Phe
X
ABCA1 p.Ser930Phe 23136402:69:66
status: NEW
view ABCA1 p.Ser930Phe details
ABCA1 p.Asp571Gly
X
ABCA1 p.Asp571Gly 23136402:69:144
status: NEW
view ABCA1 p.Asp571Gly details
ABCA1 p.Asn935Ser
X
ABCA1 p.Asn935Ser 23136402:69:118
status: NEW
view ABCA1 p.Asn935Ser details
ABCA1 p.Leu1056Pro
X
ABCA1 p.Leu1056Pro 23136402:69:171
status: NEW
view ABCA1 p.Leu1056Pro details
ABCA1 p.Ser824Leu
X
ABCA1 p.Ser824Leu 23136402:69:79
status: NEW
view ABCA1 p.Ser824Leu details
ABCA1 p.Arg579Gln
X
ABCA1 p.Arg579Gln 23136402:69:212
status: NEW
view ABCA1 p.Arg579Gln details
Subjects were carriers of the following mutations: c.6401+2T.C, p.Ser930Phe, p.Ser824Leu, p.Arg587Trp, p.Thr929Ile, p.Asn935Ser, c.3535+1G.C, p.Asp571Gly, p.Asn1800his, p.Leu1056Pro, p.Gln1038Ter, c.1195-1G.C, p.Arg579Gln, and p.Phe1760Valfs*21. Login to comment
78 ABCA1 p.Asn1800His
X
ABCA1 p.Asn1800His 23136402:78:98
status: NEW
view ABCA1 p.Asn1800His details
ABCA1 p.Thr929Ile
X
ABCA1 p.Thr929Ile 23136402:78:114
status: NEW
view ABCA1 p.Thr929Ile details
ABCA1 p.Arg587Trp
X
ABCA1 p.Arg587Trp 23136402:78:129
status: NEW
view ABCA1 p.Arg587Trp details
ABCA1 p.Leu1056Pro
X
ABCA1 p.Leu1056Pro 23136402:78:147
status: NEW
view ABCA1 p.Leu1056Pro details
Five of these mutations have already been shown to have a significant impact on ABCA1 function (p.Asn1800his,27 p.Thr929Ile,27 p.Arg587Trp,28,29 p.Leu1056Pro,21 and p.Phe1760Valfs*21.30 ). Login to comment
79 ABCA1 p.Ser930Phe
X
ABCA1 p.Ser930Phe 23136402:79:94
status: NEW
view ABCA1 p.Ser930Phe details
ABCA1 p.Asp571Gly
X
ABCA1 p.Asp571Gly 23136402:79:147
status: NEW
view ABCA1 p.Asp571Gly details
ABCA1 p.Asn935Ser
X
ABCA1 p.Asn935Ser 23136402:79:55
status: NEW
view ABCA1 p.Asn935Ser details
ABCA1 p.Ser824Leu
X
ABCA1 p.Ser824Leu 23136402:79:81
status: NEW
view ABCA1 p.Ser824Leu details
ABCA1 p.Arg579Gln
X
ABCA1 p.Arg579Gln 23136402:79:164
status: NEW
view ABCA1 p.Arg579Gln details
The efflux capacity of the remaining nine mutations: p.Asn935Ser, c.3535+1G.C, p.Ser824Leu, p.Ser930Phe, p.Gln1038Ter, c.1195-1G.C, c.6401+2T.C, p.Asp571Gly, and p.Arg579Gln are listed in Figure 1. Login to comment
81 ABCA1 p.Cys1477Arg
X
ABCA1 p.Cys1477Arg 23136402:81:53
status: NEW
view ABCA1 p.Cys1477Arg details
ABCA1 p.Val771Met
X
ABCA1 p.Val771Met 23136402:81:243
status: NEW
view ABCA1 p.Val771Met details
ABCA1 p.Arg579Gln
X
ABCA1 p.Arg579Gln 23136402:81:227
status: NEW
view ABCA1 p.Arg579Gln details
Efflux measured in fibroblasts from a heterozygous p.Cys1477Arg carrier was used as a positive control since the efflux capacity has consistently been shown to be impaired.19,27 One patient compound heterozygous for mutation p.Arg579Gln and p.Val771Met was included. Login to comment
82 ABCA1 p.Val771Met
X
ABCA1 p.Val771Met 23136402:82:71
status: NEW
view ABCA1 p.Val771Met details
ABCA1 p.Val771Met
X
ABCA1 p.Val771Met 23136402:82:165
status: NEW
view ABCA1 p.Val771Met details
ABCA1 p.Arg579Gln
X
ABCA1 p.Arg579Gln 23136402:82:149
status: NEW
view ABCA1 p.Arg579Gln details
ABCA1 p.Arg579Gln
X
ABCA1 p.Arg579Gln 23136402:82:208
status: NEW
view ABCA1 p.Arg579Gln details
In the view of contradictory statements on functionality of mutation p.Val771Met,31 we assumed that the major part of the efflux impairment of the p.Arg579Gln and p.Val771Met combination is attributable to p.Arg579Gln. Login to comment
115 ABCA1 p.Lys776Asn
X
ABCA1 p.Lys776Asn 23136402:115:301
status: NEW
view ABCA1 p.Lys776Asn details
An alternative approach is the assessment of effects of genetic variation in ABCA1 using a Mendelian randomization approach as performed by Frikke-Schmidt et al.42 In line with our results, they report that in a prospective cohort comprising 9000 individuals, heterozygosity for the ABCA1 mutation p.Lys776Asn led to a two-to-three-fold higher risk of ischaemic heart disease. Login to comment